§ Why is MRNA moving today →

Why Moderna (MRNA) Stock Fell 3.9% on November 17, 2026

-3.93%$206.80November 17, 2026 · S&P 500 -1.01%
The short answer

Moderna (MRNA) stock is down 3.9% today, trading at $206.80. This decline is notable as it is much larger than the S&P 500 ETF (SPY), which is down 1.0% in the same session, indicating that the movement is mostly specific to MRNA or its industry rather than the overall market. Recent headlines report strong results and billion-dollar deals in the biotechnology market, suggesting that while the industry is performing well, specific concerns may be impacting Moderna's stock. However, there is no single clear catalyst in the news for today's decline.

The news behind it

Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035 · GlobeNewswire Inc. · Nov 17
Before you buy or sell
Get a second opinion on MRNA
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when MRNA moves
Price, RSI and volume alerts by email or push. Free plan →

Full market recap for November 17, 2026 · What's moving MRNA today

Written from that session's quote and the headlines listed above. Educational, not financial advice.